Varenicline may have a role in the treatment of alcohol use disorder in men who smoke cigarettes.
In the US today, about 20% of adults use any type of tobacco product.
Researchers identified a DNA variant—located in the DNMT3B gene—that increases likelihood of nicotine dependence. The variant is commonly found in people of European and African descent. The discovery could create possibilities into new research for nicotine addiction treatments.
Factors including economics, environment, and demographic and social factors might put rural residents at a higher risk of these preventable causes of death.
The US Food and Drug Administration has determined that varenicline and bupropion pose a lower risk of serious mental health side effects than was previously thought.
Compared with men who never used tobacco, those who used snus but did not smoke had a 24% higher risk of death from prostate cancer.
Researchers find heavy users have lower bone density than cigarette smokers.
Cigarette smoking prevalence among persons with severe mental illness is approximately 3 times greater than the rate observed in the general population.
Maternal tobacco smoking during pregnancy has previously been linked with numerous long-term neurodevelopmental abnormalities and child behavioral problems.
Varenicline is approved by the FDA for use as a smoking cessation aid.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Amisulpride May Be Most Effective Antipsychotic for Negative Symptoms in Schizophrenia
- Frustrations With Prior Authorization: A Thorn in the Side of Clinicians
- Efficacy of Drugs for Psychosis, Relapse Prevention for Bipolar Depression, Mania
- No Evidence of Cognitive Impairment With Lisdexamfetamine Dimesylate in ADHD
- Plasma Autoantibodies Possible Biomarker for Schizophrenia
- Substance-Induced Psychosis Associated With Development of Schizophrenia, Bipolar Disorder
- Neuropsychiatric Events May Be Linked to Nitrated Nucleosome Levels in Lupus
- New APA Guideline Recommendation for Treatment of Alcohol Use Disorder
- Reducing PTSD Symptoms: Propranolol Before Reactivation Therapy
- Cannabis Use Associated With Subsequent Psychotic Experiences in Adolescents
- Cognitive Enhancement Therapy Beneficial for Neurocognitive Function in Autism
- The Crisis of Physician Suicides: Past and Present
- Affective Temperaments in Bipolar Have a Significant Impact on Functional, Clinical Outcomes of Mania
- Ketamine: A Promising Agent for Managing Treatment-Resistant Depression
- Patterns of Healthcare Use Before Diagnosis of Psychotic Disorders in Young Adults